INDEMNIFICATION AGREEMENTIndemnification Agreement • November 10th, 2015 • Ocata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of by and between Ocata Therapeutics, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
AGREEMENT AND PLAN OF MERGER DATED AS OF NOVEMBER 10, 2015 AMONG ASTELLAS PHARMA INC., LAUREL ACQUISITION INC. AND OCATA THERAPEUTICS, INC.Agreement and Plan of Merger • November 10th, 2015 • Ocata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of November 10, 2015, among ASTELLAS PHARMA INC., a company organized under the laws of Japan (“Parent”), LAUREL ACQUISITION INC., a Delaware corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”), and OCATA THERAPEUTICS, INC., a Delaware corporation (the “Company”).
SUPPORT AGREEMENTSupport Agreement • November 10th, 2015 • Ocata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of [·], 2015, is entered into by and among [·] (“Stockholder”), ASTELLAS PHARMA INC., a company organized under the laws of Japan (“Parent”), and LAUREL ACQUISITION INC., a Delaware corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”).
COMMON STOCK PURCHASE WARRANT AMENDMENT AGREEMENT OCATA THERAPEUTICS, INC.Common Stock Purchase • November 10th, 2015 • Ocata Therapeutics, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT AMENDMENT AGREEMENT (the “Agreement”) is entered into as of November 9, 2015, by and among Ocata Therapeutics, Inc., a Delaware corporation (the “Company”) and the other parties which are signatories hereto (individually, an “Investor” and collectively, the “Investors”).
